tamsulosin has been researched along with Cancer of Prostate in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (6.06) | 18.2507 |
| 2000's | 15 (45.45) | 29.6817 |
| 2010's | 14 (42.42) | 24.3611 |
| 2020's | 2 (6.06) | 2.80 |
| Authors | Studies |
|---|---|
| Basmaci, I; Bozkurt, IH; Celik, S; Ceylan, Y; Degirmenci, T; Eker, A; Gunlusoy, B; Polat, S; Sefik, E | 1 |
| Aron, M; Berger, AK; Berger, M; Desai, M; Knijnik, PG; Paludo, AO; Silva Neto, B | 1 |
| Ding, K; He, W; Liu, S; Wu, H; Zhang, T | 1 |
| Gao, G; Sun, F; Wang, K; Xue, P; Yan, M; Zhang, W | 1 |
| van Moorselaar, RJA; van Waesberghe, JHTM; Vis, AN | 1 |
| Govorov, AV; Pushkar, DY; Vasilyev, AO | 1 |
| Enomoto, Y; Fujimura, T; Fukuhara, H; Hirano, Y; Homma, Y; Kumano, S; Kume, H; Nishimatsu, H; Suzuki, M; Yamada, D | 1 |
| Ahn, H; Choo, MS; Hong, JH; Hong, S; Jeong, IG; Kim, CS; Lim, JH; Yoon, JH; You, D | 1 |
| Choi, CI; Kang, MH; Oh, JJ; Park, DS; Shin, HS; Yu, YD | 1 |
| Anoopkumar-Dukie, S; Chess-Williams, R; Forbes, A; McDermott, C | 1 |
| Alcaraz, A; Castro, R; Desgrandchamps, F; Hammerer, P; Montorsi, F; Schröder, F | 1 |
| Hanai, T; Iguchi, M; Kato, Y; Matsumoto, S; Shouji, S; Tang, XY; Terachi, T; Uemura, H; Usui, Y | 1 |
| De Nunzio, C; Mariani, S; Miano, L; Miano, R; Trucchi, A; Tubaro, A; Vicentini, C | 1 |
| Han, Y; Ku, TK; Naseri, A; Porco, TC; Rutar, T | 1 |
| Andriole, GL; Castro, R; Rittmaster, RS; Roehrborn, CG; Wilson, TH | 1 |
| Baba, S; Fujita, T; Hayakawa, K; Ishiyama, H; Kimura, M; Kitano, M; Kotani, S; Matsumoto, K; Minamida, S; Satoh, T; Tabata, K; Tsumura, H | 1 |
| Hashida, I; Hosaka, N; Iijima, K; Kamigaito, T; Nishizawa, S; Okaneya, T; Yamagishi, T | 1 |
| Kujala, PM; Murtola, TJ; Tammela, TL | 1 |
| Butler, WM; Galbreath, RW; Lief, JH; Merrick, GS; Wallner, KE | 1 |
| Keledjian, K; Kyprianou, N | 1 |
| de la Rosette, JJ; Michel, MC | 1 |
| Barqawi, A; Crawford, ED; Gamito, E; O'Donnell, C | 1 |
| Kyprianou, N; Rowland, RG; Tahmatzopoulos, A | 1 |
| Proletarskiĭ, AV; Vasil'chenko, MI; Zhukov, VF | 1 |
| Allen, Z; Butler, WM; Galbreath, RW; Lief, JH; Merrick, GS; Wallner, KE | 1 |
| Altman, A; Angermeier, KW; Chehade, N; Ciezki, JP; Elshaikh, MA; Klein, EA; Reddy, CA; Ulchaker, JC | 1 |
| Muradian, AA | 1 |
| Diebold, MD; Fremond, L; Thiefin, G | 1 |
| Flannery, M; Lowenthal, DT; Mader, SL; Nelson, RP | 1 |
| D'Amico, AV; Loffredo, M; Lopes, L; Manola, J; Prosnitz, RG; Rocha, S; Schneider, L | 1 |
| Benning, CM; Kyprianou, N | 2 |
| Benning, CM; Chon, J; Kyprianou, N | 1 |
3 review(s) available for tamsulosin and Cancer of Prostate
| Article | Year |
|---|---|
A broader role for 5ARIs in prostate disease? Existing evidence and emerging benefits.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aged; Aging; Azasteroids; Dihydrotestosterone; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Sulfonamides; Tamsulosin; Testosterone; Urinary Tract Infections | 2009 |
Efficacy and safety of tamsulosin in the treatment of urological diseases.
Topics: Adrenergic alpha-1 Receptor Antagonists; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Male; Product Surveillance, Postmarketing; Prostatic Hyperplasia; Prostatic Neoplasms; Sulfonamides; Tamsulosin; Urologic Diseases | 2004 |
The role of alpha-blockers in the management of prostate cancer.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Angiogenesis Inhibitors; Anoikis; Doxazosin; Humans; Male; Prazosin; Prostatic Neoplasms; Quinazolines; Sulfonamides; Tamsulosin | 2004 |
11 trial(s) available for tamsulosin and Cancer of Prostate
| Article | Year |
|---|---|
The effect of alpha blocker treatment prior to prostate biopsy on voiding functions, pain scores and health-related quality-of-life outcomes: A prospective randomized trial.
Topics: Adrenergic alpha-Antagonists; Aged; Humans; Image-Guided Biopsy; Male; Middle Aged; Pain; Pain Measurement; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Tamsulosin; Ultrasonography, Interventional | 2020 |
Clinical evaluation of tamsulosin in the relief of lower urinary tract symptoms in advanced prostate cancer patients.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Antineoplastic Combined Chemotherapy Protocols; Flutamide; Goserelin; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Neoplasms; Quality of Life; Severity of Illness Index; Sulfonamides; Tamsulosin; Time Factors; Urodynamics | 2017 |
Does combination therapy with tamsulosin and trospium chloride improve lower urinary tract symptoms after SEEDS brachytherapy for prostate cancer compared with tamsulosin alone? : A prospective, randomized, controlled trial.
Topics: Aged; Benzilates; Brachytherapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Nortropanes; Prospective Studies; Prostatic Neoplasms; Quality of Life; Radiation Injuries; Sulfonamides; Tamsulosin; Urodynamics | 2017 |
[Efficacy of tamsulosin for treating lower urinary tract symptoms in patients with advanced prostate cancer].
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Androgen Antagonists; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Neoplasms; Sulfonamides; Tamsulosin | 2017 |
Impact of tamsulosin on urinary retention following early catheter removal after robot-assisted laparoscopic radical prostatectomy: a prospective randomized controlled trial.
Topics: Acute Disease; Aged; Device Removal; Humans; Laparoscopy; Logistic Models; Male; Middle Aged; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Risk Assessment; Robotics; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Treatment Outcome; Urinary Catheterization; Urinary Retention; Urological Agents | 2014 |
Effect of dutasteride on prostate biopsy rates and the diagnosis of prostate cancer in men with lower urinary tract symptoms and enlarged prostates in the Combination of Avodart and Tamsulosin trial.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Aged; Azasteroids; Biopsy; Drug Therapy, Combination; Dutasteride; Humans; Incidence; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Risk Factors; Sulfonamides; Tamsulosin; Urination Disorders | 2011 |
Comparison of prophylactic naftopidil, tamsulosin, and silodosin for 125I brachytherapy-induced lower urinary tract symptoms in patients with prostate cancer: randomized controlled trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Analysis of Variance; Brachytherapy; Humans; Indoles; Iodine Radioisotopes; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Prostatic Neoplasms; Quality of Life; Radiotherapy Dosage; Sulfonamides; Tamsulosin | 2011 |
Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy.
Topics: Adenocarcinoma; Adrenergic alpha-Antagonists; Biopsy; Brachytherapy; Doxazosin; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Palladium; Postoperative Complications; Prazosin; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Conformal; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Retention; Urination Disorders | 2002 |
Brachytherapy-related dysuria.
Topics: Adrenergic alpha-Antagonists; Aged; Antineoplastic Agents; Brachytherapy; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Quality of Life; Severity of Illness Index; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders | 2005 |
Prophylactic tamsulosin (Flomax) in patients undergoing prostate 125I brachytherapy for prostate carcinoma: final report of a double-blind placebo-controlled randomized study.
Topics: Adenocarcinoma; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Analysis of Variance; Area Under Curve; Brachytherapy; Double-Blind Method; Humans; Iodine Radioisotopes; Male; Middle Aged; Prostatic Neoplasms; Sulfonamides; Tamsulosin; Urinary Retention; Urination Disorders | 2005 |
[Alfa-blockade with doxazosin vs tamsulozin in combination of intermittent androgen blockade in patients with prostate cancer].
Topics: Adrenergic alpha-Antagonists; Aged; Androgen Antagonists; Antineoplastic Agents; Doxazosin; Drug Therapy, Combination; Flutamide; Humans; Male; Middle Aged; Prostatic Neoplasms; Sulfonamides; Tamsulosin; Urodynamics | 2005 |
19 other study(ies) available for tamsulosin and Cancer of Prostate
| Article | Year |
|---|---|
Initial experience with first postoperative day Foley catheter removal after robot-assisted radical prostatectomy.
Topics: Device Removal; Enhanced Recovery After Surgery; Erectile Dysfunction; Humans; Male; Middle Aged; Postoperative Care; Postoperative Complications; Prostatectomy; Prostatic Neoplasms; Robotic Surgical Procedures; Tamsulosin; Time Factors; Urinary Catheters; Urinary Incontinence; Urinary Retention; Urological Agents | 2021 |
Primary Treatment for Prostate Cancer in an Elderly Man.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged, 80 and over; Digital Rectal Examination; Humans; Lower Urinary Tract Symptoms; Male; Neoplasm Grading; Prostate-Specific Antigen; Prostatic Neoplasms; Robotic Surgical Procedures; Tamsulosin; Treatment Outcome; Ultrasound, High-Intensity Focused, Transrectal | 2017 |
Reduction of prostate cancer incidence by naftopidil, an α1 -adrenoceptor antagonist and transforming growth factor-β signaling inhibitor.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Apoptosis; Cell Line, Tumor; HeLa Cells; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Naphthalenes; Piperazines; Proportional Hazards Models; Prostatic Neoplasms; Retrospective Studies; Risk Factors; Signal Transduction; Sulfonamides; Tamsulosin; Transforming Growth Factor beta | 2013 |
Clinical efficacy of combination therapy with an alpha blocker and low-dose sildenafil on post-therapy lower urinary tract symptoms after low-dose-rate brachytherapy for prostate cancer.
Topics: Adrenergic alpha-Antagonists; Aged; Brachytherapy; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prospective Studies; Prostatic Neoplasms; Radiotherapy Dosage; Sildenafil Citrate; Sulfonamides; Tamsulosin; Treatment Outcome | 2016 |
Relative cytotoxic potencies and cell death mechanisms of α1 -adrenoceptor antagonists in prostate cancer cell lines.
Topics: Adrenergic alpha-1 Receptor Antagonists; Antineoplastic Agents; Apoptosis; Autophagy; Cell Death; Cell Line, Tumor; Cell Survival; Doxazosin; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indoles; Male; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Prazosin; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Sulfonamides; Tamsulosin | 2016 |
[The changes of prostate specific antigen (PSA) after treatment with alpha 1-adrenergic receptor antagonists in men with 4.0-9.9 ng/ml PSA level--a study for comparison of benign prostatic hyperplasia/lower urinary tract symptom (BPH/LUTS) and prostate ca
Topics: Adrenergic alpha-Antagonists; Aged; Humans; Male; Prospective Studies; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Sulfonamides; Tamsulosin; Urinary Retention | 2009 |
Reduction of prostate-specific antigen after tamsulosin treatment in patients with elevated prostate-specific antigen and lower urinary tract symptoms associated with low incidence of prostate cancer at biopsy.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Biopsy; Humans; Incidence; Male; Middle Aged; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Prostatism; Sulfonamides; Tamsulosin | 2010 |
Resident-performed phacoemulsification surgery in tamsulosin-treated patients.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Humans; Internship and Residency; Intraoperative Complications; Iris Diseases; Male; Ophthalmology; Phacoemulsification; Practice Patterns, Physicians'; Prostatic Hyperplasia; Prostatic Neoplasms; Retrospective Studies; Sulfonamides; Tamsulosin; Visual Acuity | 2010 |
[Clinical evaluation of lower urinary tract symptoms following seed implant for prostate cancer].
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Brachytherapy; Humans; Iodine Radioisotopes; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Neoplasms; Quality of Life; Radiography; Sulfonamides; Tamsulosin | 2012 |
High-grade prostate cancer and biochemical recurrence after radical prostatectomy among men using 5α-reductase inhibitors and alpha-blockers.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Azasteroids; Cohort Studies; Disease-Free Survival; Dutasteride; Finasteride; Finland; Humans; Kallikreins; Male; Neoplasm Grading; Neoplasm Recurrence, Local; Proportional Hazards Models; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Quinazolines; Sulfonamides; Survival Rate; Tamsulosin | 2013 |
Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Anoikis; Cell Adhesion; Cell Survival; Doxazosin; Endothelial Growth Factors; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Intercellular Signaling Peptides and Proteins; Lymphokines; Male; Neoplasm Invasiveness; Prazosin; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Tamsulosin; Transcription Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Herbal and vitamin supplement use in a prostate cancer screening population.
Topics: Adenocarcinoma; Adrenergic alpha-Antagonists; Adult; Aged; Colorado; Complementary Therapies; Dietary Supplements; Doxazosin; Drug Utilization; Family; Finasteride; Health Surveys; Humans; Male; Mass Screening; Middle Aged; Penile Erection; Phytotherapy; Plant Preparations; Prazosin; Prostatic Hyperplasia; Prostatic Neoplasms; Self Medication; Socioeconomic Factors; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Urination Disorders; Vitamins | 2004 |
[Surveillance of prostate adenoma patients administering selective alpha-1a-adrenoblocker].
Topics: Adenoma; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Antineoplastic Agents; Clinical Trials as Topic; Humans; Male; Middle Aged; Prostatic Neoplasms; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Treatment Outcome | 2004 |
[Acute pseudoangiocholitic hepatitis probably induced by tamsulosin].
Topics: Acute Disease; Adenoma; Aged; Antineoplastic Agents; Biopsy; Chemical and Drug Induced Liver Injury; Cholangitis; Diagnosis, Differential; Gilbert Disease; Humans; Liver; Male; Prostatic Neoplasms; Sulfonamides; Tamsulosin | 2006 |
Benign prostatic hyperplasia: maximizing treatment with alpha blockers.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Humans; Hypertension; Hypotension, Orthostatic; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Sulfonamides; Tamsulosin; Urodynamics | 1998 |
Tamsulosin palliates radiation-induced urethritis in patients with prostate cancer: results of a pilot study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Humans; Male; Palliative Care; Pilot Projects; Prostatic Neoplasms; Radiation Injuries; Sulfonamides; Tamsulosin; Urethritis | 1999 |
Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Antagonists; Animals; Antineoplastic Agents; Apoptosis; Cell Division; Cells, Cultured; Doxazosin; Growth Inhibitors; Humans; Male; Mice; Mice, SCID; Muscle, Smooth; Neoplasm Transplantation; Prazosin; Prostate; Prostatic Neoplasms; Receptors, Adrenergic, alpha-1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Tamsulosin; Transplantation, Heterologous | 2000 |
Effects of alpha(1)-adrenoceptor (alpha(1)-AR) antagonists on cell proliferation and apoptosis in the prostate: therapeutic implications in prostatic disease.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Apoptosis; Biopsy; Cell Division; Doxazosin; Humans; Male; Muscle, Smooth; Prazosin; Prostate; Prostatic Diseases; Prostatic Hyperplasia; Prostatic Neoplasms; Stromal Cells; Sulfonamides; Tamsulosin | 2000 |
Quinazoline-derived alpha1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an alpha1-adrenoceptor-independent action.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Apoptosis; Dose-Response Relationship, Drug; Doxazosin; Humans; Male; Prazosin; Prostatic Neoplasms; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Tumor Cells, Cultured | 2002 |